Biotech Archives

Healthcare Industry News Weekly Wrap-Up: December 30, 2022

// Biotech and Pharma Therapeutics Drug companies set sights on new Covid medicines to boost depleted arsenal December 28, 2022 / COVID / New Drug / AstrZeneca It was not that long ago that the medical community had a small...

December 30, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 23, 2022

// Biotech and Pharma Therapeutics Pfizer snaps up rights to RSV therapy left behind in ReViral buy for $20M December 19, 2022 / Pfizer / RSV / LianBio / Licensing Deals Pfizer, looking to be the king in respiratory syncytial...

December 23, 2022

Weekly Wrap-Up

Pharma Industry News Weekly Recap: December 16, 2023

// Biotech and Pharma Therapeutics A San Diego startup sees covalent biologics as the next frontier in cancer drugs December 15, 2022 / San Diego / Cancer Drugs / Enlaza Therapeutics / Startup Enlaza’s approach involves introducing what it describes...

December 16, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 9, 2022

December 9, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 2, 2022

// Biotech and Pharma Therapeutics AstraZeneca beefs up COPD pipeline with $400M biobuck bet on C4X program November 28, 2022 / AstraZeneca / Chronic Obstructive Pulmonary Disease / Licensing Deals / Respiratory Diseases AstraZeneca has moved to strengthen its respiratory...

December 2, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: September 16, 2022

// Biotech and Pharma Therapeutics Eli Lilly touts early demand for high-stakes diabetes launch Mounjaro: analysts September 14, 2022 / Mounjaro / Tirzepatide / Type 2 Diabetes After snaring approval in May, Eli Lilly’s closely watched diabetes med tirzepatide—now christened...

September 16, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: September 9, 2022

// Biotech and Pharma Therapeutics Bayer, Regeneron’s eye drug shown to work at higher dose, longer intervals September 8, 2022 / Age-related Macular Degeneration / Diabetic Macular Oedema Bayer (BAYGn.DE)said on Thursday its anti-blindness treatment Eylea, jointly developed with Regeneron...

September 9, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: September 2, 2022

// Biotech and Pharma Therapeutics Novartis Nabs Merck Veteran to Helm BioMedical Institutes September 1, 2022 / Novartis / Business / Oncology Merck veteran Fiona H. Marshall has been tapped as president of the Novartis Institutes for BioMedical Research (NIBR)....

September 2, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: August 25, 2022

// Biotech and Pharma Therapeutics Backed by $40M, a biotech startup targets cancer with help from the immune system August 16, 2022 / Cancer / Biotech / Startups M3T Biosciences is emerging from stealth with plans to develop therapies based...

August 25, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: August 18, 2022

// Biotech and Pharma Therapeutics CRISPR offers genetic clues to Alzheimer’s in brain’s cleaning crew August 16, 2022 / CRISPR / Neuroscience / Alzheimer’s Microglia clear out the brain’s cellular debris and play a central role in maintaining the health...

August 18, 2022

1 2 3 4

Tag: Biotech

Healthcare Industry News Weekly Wrap-Up: December 30, 2022

Healthcare Industry News Weekly Wrap-Up: December 23, 2022

Pharma Industry News Weekly Recap: December 16, 2023

Healthcare Industry News Weekly Wrap-Up: December 9, 2022

Healthcare Industry News Weekly Wrap-Up: December 2, 2022

Healthcare Industry News Weekly Wrap-Up: September 16, 2022

Healthcare Industry News Weekly Wrap-Up: September 9, 2022

Healthcare Industry News Weekly Wrap-Up: September 2, 2022

Healthcare Industry News Weekly Wrap-Up: August 25, 2022

Healthcare Industry News Weekly Wrap-Up: August 18, 2022

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy⁺

About Vault

Tag: Biotech

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy+

About Vault

Strategy⁺